✦ LIBER ✦

6518 ORAL Subgroup results from a randomised, double-blind, multicentre phase III study of bevacizumab in combination with cisplatingemcitabine in chemotherapy-naive patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): study BO17704

✍ Scribed by Eberhardt, W.; Reck, M.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Leighl, N.; Mezger, J.; Moore, N.; Manegold, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6503 ORAL Efficacy and safety results fr

✍ Manegold, C.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Hirsh, V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

6509 ORAL Management of hypertension (HT

✍ Bennouna, J.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Hirsh, V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

6570 POSTER Results for progression-free

✍ Sandler, A.; Reck, M.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

9003 ORAL Biomarker Analysis in BO21015,

✍ Mok, T.; Gorbunova, V.; Juhasz, E.; Szima, B.; Burdaeva, O.; Yu, C.J.; Delmar, P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

6594 POSTER First-line bevacizumab in co

✍ Crinó, L.; Dansin, E.; Garrido Lopez, P.; Griesinger, F.; Laskin, J.; Pavlakis, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

223 Docetaxel in combination with vinore

✍ Douillard, J.Y.; Monnier, A.; Le Chevalier, T.; Aapro, M.; Nahon, S.; Sun, X.S.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 141 KB